Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
70
CARE Quote, Financials, Valuation and Earnings
Last price:
$18.21
Seasonality move
:
0.51%
Day range:
$17.63 - $18.04
52-week range:
$13.61 - $20.40
Dividend yield:
0%
P/E ratio:
14.94x
P/S ratio:
3.02x
P/B ratio:
1.03x
Volume:
70K
Avg. volume:
103K
1-year change:
7.43%
Market cap:
$415.2M
Revenue:
$132.4M
EPS (TTM):
$1.20
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $127.9M | $133.7M | $158.9M | $137.7M | $132.4M | |
| Revenue Growth (YoY) | 5.21% | 4.47% | 18.88% | -13.33% | -3.86% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $56.3M | $57.3M | $55.8M | $62.5M | $66.6M | |
| Other Inc / (Exp) | $6.9M | $6.9M | $46K | -$1.5M | $68K | |
| Operating Expenses | -$6M | $57.3M | $55.8M | $62.5M | $66.6M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$45.1M | $35.7M | $61.7M | $28.7M | $30.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $772K | $4.1M | $11.6M | $5.3M | $6.3M | |
| Net Income to Company | -$45.9M | $31.6M | $50.1M | $23.4M | $24.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$45.9M | $31.6M | $50.1M | $23.4M | $24.5M | |
| Basic EPS (Cont. Ops) | -$1.74 | $1.19 | $2.03 | $1.00 | $1.06 | |
| Diluted EPS (Cont. Ops) | -$1.74 | $1.19 | $2.03 | $1.00 | $1.06 | |
| Weighted Average Basic Share | $26.4M | $26.3M | $24.6M | $23.2M | $22.8M | |
| Weighted Average Diluted Share | $26.4M | $26.3M | $24.6M | $23.2M | $22.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$9.3M | $58.4M | $82M | $102.8M | $138.1M | |
| Revenue (Reported) | $127.9M | $133.7M | $158.9M | $137.7M | $132.4M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$9.3M | $58.4M | $82M | $102.8M | $138.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $34.6M | $32.5M | $45M | $32.7M | $36M | |
| Revenue Growth (YoY) | 6.61% | -6.05% | 38.41% | -27.38% | 10.21% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $14.9M | $12.4M | $14.6M | $16.2M | $16M | |
| Other Inc / (Exp) | $3.6M | -$24K | -$12K | -- | -- | |
| Operating Expenses | $14.9M | $12.7M | $14.6M | $16.2M | $16M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $10.3M | $10.7M | $20.4M | $7.2M | $11.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $926K | $1.3M | $4.5M | $1.4M | $2.2M | |
| Net Income to Company | $9.4M | $9.3M | $15.9M | $5.8M | $9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9.4M | $9.3M | $15.9M | $5.8M | $9M | |
| Basic EPS (Cont. Ops) | $0.36 | $0.36 | $0.67 | $0.25 | $0.39 | |
| Diluted EPS (Cont. Ops) | $0.36 | $0.36 | $0.67 | $0.25 | $0.39 | |
| Weighted Average Basic Share | $26.3M | $25.7M | $23.8M | $22.8M | $22.9M | |
| Weighted Average Diluted Share | $26.3M | $25.7M | $23.8M | $22.8M | $22.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $16.7M | $15.1M | $31.6M | $32.9M | $37M | |
| Revenue (Reported) | $34.6M | $32.5M | $45M | $32.7M | $36M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $16.7M | $15.1M | $31.6M | $32.9M | $37M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $130.1M | $131.6M | $171.4M | $125.4M | $135.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $55.5M | $54.7M | $58.6M | $64.5M | $66.7M | |
| Other Inc / (Exp) | $9.3M | $3.2M | $58K | -$1.5M | $68K | |
| Operating Expenses | -$6.9M | $55.1M | $59.3M | $64.5M | $66.7M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$39.5M | $36M | $71.5M | $15.5M | $34.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.5M | $4.5M | $14.8M | $2.3M | $7.1M | |
| Net Income to Company | -$40.9M | $31.5M | $56.7M | $13.3M | $27.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$40.9M | $31.5M | $56.7M | $13.3M | $27.7M | |
| Basic EPS (Cont. Ops) | -$1.55 | $1.20 | $2.35 | $0.57 | $1.20 | |
| Diluted EPS (Cont. Ops) | -$1.55 | $1.20 | $2.35 | $0.57 | $1.20 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$7.8M | $56.8M | $98.5M | $104.1M | $142.3M | |
| Revenue (Reported) | $130.1M | $131.6M | $171.4M | $125.4M | $135.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$7.8M | $56.8M | $98.5M | $104.1M | $142.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $34.6M | $32.5M | $45M | $32.7M | $36M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $14.9M | $12.4M | $14.6M | $16.2M | $16M | |
| Other Inc / (Exp) | $3.6M | -$24K | -$12K | -- | -- | |
| Operating Expenses | $14.9M | $12.7M | $14.6M | $16.2M | $16M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $10.3M | $10.7M | $20.4M | $7.2M | $11.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $926K | $1.3M | $4.5M | $1.4M | $2.2M | |
| Net Income to Company | $9.4M | $9.3M | $15.9M | $5.8M | $9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9.4M | $9.3M | $15.9M | $5.8M | $9M | |
| Basic EPS (Cont. Ops) | $0.36 | $0.36 | $0.67 | $0.25 | $0.39 | |
| Diluted EPS (Cont. Ops) | $0.36 | $0.36 | $0.67 | $0.25 | $0.39 | |
| Weighted Average Basic Share | $26.3M | $25.7M | $23.8M | $22.8M | $22.9M | |
| Weighted Average Diluted Share | $26.3M | $25.7M | $23.8M | $22.8M | $22.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $16.7M | $15.1M | $31.6M | $32.9M | $37M | |
| Revenue (Reported) | $34.6M | $32.5M | $45M | $32.7M | $36M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $16.7M | $15.1M | $31.6M | $32.9M | $37M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $241.9M | $277.8M | $46.9M | $54.5M | $131.2M | |
| Short Term Investments | $778.7M | $922.4M | $836.3M | $719.6M | $655M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1B | $1.2B | $883.1M | $833.5M | $849.6M | |
| Property Plant And Equipment | $85.3M | $75.3M | $72.1M | $73.7M | $74.3M | |
| Long-Term Investments | $778.7M | $922.4M | $836.3M | $719.6M | $665M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4.2B | $4.1B | $4.2B | $4.5B | $4.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $17.9M | -- | -- | |
| Long-Term Debt | $35M | $7M | $180.6M | $393.4M | $70M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.7B | $3.7B | $3.9B | $4.2B | $4.3B | |
| Common Stock | $26.4M | $26.4M | $24M | $23M | $23.1M | |
| Other Common Equity Adj | -- | $1.7M | -$85.6M | -$71.4M | -$64.5M | |
| Common Equity | $440.2M | $407.6M | $328.6M | $351.2M | $384.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $440.2M | $407.6M | $328.6M | $351.2M | $384.3M | |
| Total Liabilities and Equity | $4.2B | $4.1B | $4.2B | $4.5B | $4.7B | |
| Cash and Short Terms | $1B | $1.2B | $883.1M | $774.2M | $786.1M | |
| Total Debt | $35M | $7M | $180.6M | $393.4M | $70M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $219.2M | $108M | $81.4M | $108.1M | $89M | |
| Short Term Investments | $780M | $982M | $862.9M | $708.8M | $681.6M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $999.2M | $1.1B | $944.2M | $876.9M | $834.4M | |
| Property Plant And Equipment | $85.3M | $73.4M | $72.5M | $73.3M | $73.9M | |
| Long-Term Investments | $780M | $982M | $862.9M | $708.8M | $691.8M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4.1B | $4.1B | $4.4B | $4.6B | $4.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $30M | -- | $435.1M | $310.5M | $55M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.8B | $3.8B | $4B | $4.2B | $4.3B | |
| Common Stock | $26.5M | $25M | $23.9M | $23M | $23.2M | |
| Other Common Equity Adj | -- | -$32.3M | -$73.4M | -$69.8M | -$56.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $387.9M | $358.6M | $354.9M | $359.1M | $401.8M | |
| Total Liabilities and Equity | $4.1B | $4.1B | $4.4B | $4.6B | $4.7B | |
| Cash and Short Terms | $999.2M | $1.1B | $944.2M | $816.9M | $770.6M | |
| Total Debt | $30M | -- | $435.1M | $310.5M | $55M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$45.9M | $31.6M | $50.1M | $23.4M | $24.5M | |
| Depreciation & Amoritzation | $6.1M | $6.2M | $6.1M | $6.2M | $7.1M | |
| Stock-Based Compensation | $1M | $1M | $1.3M | $1.6M | $1.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.7M | $77.5M | $70.8M | $46.7M | $36.9M | |
| Capital Expenditures | $10.1M | $8.5M | $5.9M | $9.8M | $8.1M | |
| Cash Acquisitions | -- | -$73.9M | -- | -- | -- | |
| Cash From Investing | -$93.3M | -$106.4M | -$382.1M | -$307M | -$68.4M | |
| Dividends Paid (Ex Special Dividend) | -$3.7M | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $25M | -- | $300.6M | $3.4B | $1.9B | |
| Long-Term Debt Repaid | -- | -- | -$127M | -$3.2B | -$2.2B | |
| Repurchase of Common Stock | -- | -$157K | -$42.9M | -$16.4M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $201.7M | $64.7M | $80.4M | $267.9M | $108.1M | |
| Beginning Cash (CF) | $125.8M | $241.9M | $277.8M | $46.9M | $54.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $116.1M | $35.9M | -$230.9M | $7.7M | $76.6M | |
| Ending Cash (CF) | $241.9M | $277.8M | $46.9M | $54.5M | $131.2M | |
| Levered Free Cash Flow | -$2.4M | $69.1M | $64.9M | $36.9M | $28.8M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $5.4M | $10.8M | $5.7M | $4.8M | -- | |
| Depreciation & Amoritzation | $1.6M | $1.5M | $1.6M | $1.8M | -- | |
| Stock-Based Compensation | $291K | $309K | $431K | $425K | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $23.1M | $14.3M | $7.2M | -$2.5M | -- | |
| Capital Expenditures | $1.6M | $1.7M | $4.1M | $1.8M | -- | |
| Cash Acquisitions | -$73.9M | -- | -- | -- | -- | |
| Cash From Investing | -$72.4M | -$68.2M | -$50.9M | -$22.2M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -$28M | -$903.5M | -- | |
| Long-Term Debt Repaid | -- | -- | $7.9M | $831M | -- | |
| Repurchase of Common Stock | -- | -$9.1M | -$7.8M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $46.8M | $16.1M | $15.7M | -$21.7M | -- | |
| Beginning Cash (CF) | $219.2M | $108M | $81.4M | $108.1M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.5M | -$37.8M | -$28.1M | -$46.4M | -- | |
| Ending Cash (CF) | $216.7M | $70.2M | $53.3M | $61.7M | -- | |
| Levered Free Cash Flow | $21.5M | $12.6M | $3.1M | -$4.3M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$40.9M | $31.5M | $56.7M | $13.3M | $27.7M | |
| Depreciation & Amoritzation | $6.2M | $6.1M | $6.1M | $6.4M | $7.3M | |
| Stock-Based Compensation | $872K | $1.2M | $1.3M | $1.7M | $1.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $13.1M | $89.6M | $80.8M | $41.9M | $25.7M | |
| Capital Expenditures | $7.2M | $7.7M | $7M | $9.2M | $8.4M | |
| Cash Acquisitions | -- | -$73.9M | -- | -- | -- | |
| Cash From Investing | -$70.8M | -$263M | -$325.9M | -$171.3M | -$159.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $4.1B | -- | |
| Long-Term Debt Repaid | -- | -- | -$137.9M | -$4.2B | -$1.2B | |
| Repurchase of Common Stock | -- | -$23.5M | -$21.8M | -$14.2M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $213.5M | $62.2M | $218.4M | $156.1M | $114.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $155.8M | -$111.1M | -$26.7M | $26.7M | -$19.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $5.9M | $82M | $73.8M | $32.8M | $17.3M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14.8M | $20.1M | $21.6M | $10.6M | $9M | |
| Depreciation & Amoritzation | $3.1M | $3M | $3.1M | $3.4M | $1.9M | |
| Stock-Based Compensation | $499K | $704K | $776K | $866K | $481K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $23.4M | $26.8M | $29.6M | $15.2M | $6.4M | |
| Capital Expenditures | $3.2M | $2.5M | $6M | $3.1M | $1.5M | |
| Cash Acquisitions | -$73.9M | -- | -- | -- | -- | |
| Cash From Investing | -$97.4M | -$249.9M | -$176.4M | -$11.9M | -$81.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $226.6M | -- | $25M | |
| Long-Term Debt Repaid | -$5M | -$7M | -$10M | -$155.4M | -$40M | |
| Repurchase of Common Stock | -- | -$32.4M | -$10.1M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $48.7M | $15.5M | $153.2M | $4M | $32.5M | |
| Beginning Cash (CF) | $461.1M | $385.8M | $128.2M | $162.6M | $131.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$25.3M | -$207.6M | $6.4M | $7.2M | -$42.2M | |
| Ending Cash (CF) | $435.8M | $178.3M | $134.7M | $169.9M | $89M | |
| Levered Free Cash Flow | $20.2M | $24.3M | $23.6M | $12.1M | $4.9M | |
Get CARE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CARE
Sector
P/E ratio
14.94x
12.18x
PEG ratio
0.14x
0.40x
P/B ratio
1.03x
1.10x
Price / LTM sales
3.02x
2.66x
Growth Metrics
CARE
Sector
Revenue growth
10.21%
5.1%
Earnings growth
56%
2.61%
Revenue (5-year growth)
1.72%
5.17%
Earnings forecast
$0.32
$0.61
Profitability
CARE
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
5.2%
5.2%
Return on assets
0.6%
0.97%
Return on equity
7.29%
9.24%
Earnings Date
Last Earnings Date
Apr
24
Next Earnings Date
Jul
25
Estimated Next Earnings Date
Jul
24
Balance Sheet
CARE
Sector
Total cash
$770.6M
$452M
Short term investments
$655M
$220.9M
Total assets
$4.7B
$3.8B
Long term debt
$55M
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
